HALO logo
halo search icon
Inhibikase Therapeutics, Inc.

US$1.68

Price Change Indicator
0.11 (7.01%)
Inhibikase Therapeutics, Inc.
IKT · NAS

Inhibikase Therapeutics, Inc.

Start Trading IKT for Free

US$1.68

Price Arrow0.11 (7.01%)
20/05/2026 04:00:00 PM
All-CompaniesAll-ConsensusBig CandleHALO AllHALO Consensus ValueHALO Earnings MomentumRecent Earnings upgrade
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Inhibikase Therapeutics, Inc. Overview

IKT Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Weak

Earnings

Very Strong

Growth

Earnings

Neutral

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Weak

About IKT

icon

Website

Inhibikase Therapeutics, Inc.

icon

Telephone

1.302.295.3800

icon

Address

Suite 1200, 1000 North West Street, Wilmington, DE 19801

Description

Inhibikase Therapeutics, Inc. is a clinical-stage pharmaceutical company, which engages in development of protein kinase inhibitor therapeutics to modify the course of Parkinson's-related disorders and other diseases of the Abelson Tyrosine Kinases. It also focuses on neurodegeneration and its lead program IkT-148009, an Abelson Tyrosine Kinase (c-Abl) inhibitor, targets the treatment of Parkinson's disease inside and outside the brain as well as other diseases that arise from Ableson Tyrosine Kinases. The company was founded by Milton H. Werner in September 2008 and is headquartered in Wilmington, DE.

IKT Price Chart

Key Stats

Market Cap

US$207.29M

PE

0.00

EV/EBITDA

N/A

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 1.33 - 2.26

Trade Value (12mth)

US$329,007.00

1 week

-9.25%

1 month

-5.99%

YTD

-19.49%

1 year

-20.3%

All time high

70.80

Key Fundamentals

EPS 3 yr Growth

-88.60%

EBITDA Margin

0.00%

Operating Cashflow

-$28m

Free Cash Flow Return

-20.80%

ROIC

-36.00%

Interest Coverage

0.00

Quick Ratio

21.70

Other Data

Shares Outstanding (Fully Diluted)

172m

HALO Sector

Healthcare

Next Company Report Date

01-Apr-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

IKT Announcements

Latest Announcements

DateAnnouncements
13 May 26
13 May 26
13 May 26
13 May 26
07 April 26

IKT Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
 $locklocklocklock-3.57-1.16-0.49locklocklock
EPS (Fully Diluted)
 $locklocklocklock-3.57-1.16-0.49locklocklock
Growth
 %locklocklocklock1767.557.7locklocklock
PE
 XlocklocklocklockN/AN/AN/Alocklocklock
EV/EBITDA
 XlocklocklocklockN/AN/AN/Alocklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of Inhibikase Therapeutics, Inc. (IKT:NAS)?
Halo FAQ
The current share price of Inhibikase Therapeutics, Inc. (IKT:NAS) is USD$1.68.
What is the 52-week high share price for Inhibikase Therapeutics, Inc. (IKT:NAS)?
Halo FAQ
The 52-week high share price for Inhibikase Therapeutics, Inc. (IKT:NAS) is USD$2.26.
What is the 52-week low share price for Inhibikase Therapeutics, Inc. (IKT:NAS)?
Halo FAQ
The 52-week low share price for Inhibikase Therapeutics, Inc. (IKT:NAS) is USD$1.33.
What is the dividend yield for Inhibikase Therapeutics, Inc. (IKT:NAS)?
Halo FAQ
Inhibikase Therapeutics, Inc. (IKT:NAS) does not pay a dividend.
What was Inhibikase Therapeutics, Inc. (IKT:NAS) last dividend payment?
Halo FAQ
Inhibikase Therapeutics, Inc. (IKT:NAS) does not pay a dividend.
What is the franking level for Inhibikase Therapeutics, Inc. (IKT:NAS)?
Halo FAQ
Inhibikase Therapeutics, Inc. (IKT:NAS) has a franking level of 0.00%.
In which sector is Inhibikase Therapeutics, Inc. (IKT:NAS) classified?
Halo FAQ
Inhibikase Therapeutics, Inc. (IKT:NAS) is classified in the Healthcare.

See beyond the curve.

One solution for research, investing and portfolio management.
Start FREE Trial